Morgan Stanley’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | -$4 | – | 8101 |
|
|
2025
Q1 | – | Sell |
-11
| Closed | -$13.9K | – | 8037 |
|
|
2024
Q4 | $16.9K | Buy |
+11
| New | +$31.6K | ﹤0.01% | 6622 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7688 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7449 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7180 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7036 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6987 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6636 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6581 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6560 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6347 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6387 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5696 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5162 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6085 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6052 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6026 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5837 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6503 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5542 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6446 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6364 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6466 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6632 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6584 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6477 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6117 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5609 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5572 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 5595 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 5443 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 5219 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 5220 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4984 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4338 |
|
Other funds holding APVO
Morgan Stanley's APVO Position: Q2 2025 in Review
Morgan Stanley held its Aptevo Therapeutics (APVO) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8101.
Morgan Stanley first reported a position in APVO in Q4 2024 and has held it in 1 quarter since. The position peaked at $16.9K in Q4 2024. 4 funds tracked by Wall St. Rank hold APVO as of Q2 2025.
- Morgan Stanley held 0 shares of Aptevo Therapeutics worth $0 as of Q2 2025.
- Morgan Stanley left its Aptevo Therapeutics share count unchanged in Q2 2025.
- Aptevo Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2025, its #8101 holding.
- Morgan Stanley first reported a position in Aptevo Therapeutics in Q4 2024 and has held it in 1 quarter since.
- Morgan Stanley's Aptevo Therapeutics position peaked at $16.9K in Q4 2024.
- 4 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q2 2025.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.